Loading clinical trials...

COMPLETEDPhase 4NCT00490191

Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency

This study tested whether a dose regimen of growth hormone based on body weight is equivalent or better than starting with a low dose and gradually increasing the dose according to individual patient ...

Lead sponsor: Eli Lilly and Company•21 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

NCT00001595 · Panhypopituitarism, Gigantism/Acromegaly, and more

RECRUITING

GROWing Up With Rare GENEtic Syndromes

NCT04463316 · Prader-Willi Syndrome, PWS-like Syndrome, and more

COMPLETEDPhase 4

Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)

NCT04897802 · Hypopituitarism, Central Diabetes Insipidus, and more

COMPLETEDPhase 4

Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)

NCT04902235 · Hypopituitarism, Central Diabetes Insipidus, and more

UNKNOWNEARLY Phase 1

The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

NCT06217848 · Panhypopituitarism, Craniopharyngioma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 22, 2007Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment387

Start dateJan 1999

Last updatedJun 22, 2007

Condition

Hypopituitarism

Locations shown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Irvine, California

La Jolla, California

Palo Alto, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 22, 2007Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions